TITLE

mRNA Expression of NANOG and OCT4 in Human Embryos

AUTHOR(S)
Stavreus-Evers, A.
PUB. DATE
March 2013
SOURCE
Fertility Weekly;3/25/2013, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on study on human embryonic stem cells. The messenger RNA (mRNA) expression of homeobox proteins transcription factor (NANOG) can be localized using in situ hybridization in these cells. This was performed by down regulation of ovarian hyperstimulation utilized gonadotropin-releasing hormone agonist (GnRHA) followed by inducing of recombinant follicle-stimulating hormone (FSH) in human embryos. The results showed that NANOG in humans plays a role in embryonic development.
ACCESSION #
86433772

 

Related Articles

  • Follitropin-α/lutropin-α.  // Reactions Weekly;10/1/2011, Issue 1371, p17 

    The article describes the case of a 34-year-old woman with hyperprolactinaemia who developed ovarian hyperstimulation syndrome after receiving follitropin-α and lutropin-α.

  • Co-localization of NANOG and OCT4 in human pre-implantation embryos and in human embryonic stem cells. Hambiliki, Fredwell; Ström, Susanne; Zhang, Pu; Stavreus-Evers, Anneli // Journal of Assisted Reproduction & Genetics;Oct2012, Vol. 29 Issue 10, p1021 

    Purpose: NANOG and OCT4 are required for the maintenance of pluripotency in embryonic stem cells (ESCs). These proteins are also expressed in the inner cell mass (ICM) of the mouse pre-implantation embryo. Methods: Immunohistochemistry was used to show the presence of NANOG and OCT4 protein, and...

  • Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain. Seymour, Tracy; Twigger, Alecia-Jane; Kakulas, Foteini // International Journal of Molecular Sciences;Nov2015, Vol. 16 Issue 11, p27288 

    Pluripotent stem cells (PSCs) attracted considerable interest with the successful isolation of embryonic stem cells (ESCs) from the inner cell mass of murine, primate and human embryos. Whilst it was initially thought that the only PSCs were ESCs, in more recent years cells with similar...

  • Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction. Serour, Gamal I.; Aboulghar, Mohamed; Al Bahar, Awatef; Hugues, Jean-Noel; Esmat, Khaled // Reproductive Biology & Endocrinology;2014, Vol. 12 Issue 1, p1 

    Background This Phase IV, open-label, multicentre, randomized study (MEnTOR) compared two lowdose recombinant human follicle-stimulating hormone (r-hFSH) protocols for ovulation induction. Methods This study was conducted in six Middle Eastern countries between March 2009 and March 2011....

  • Oocyte Number as a Predictor of OHSS and Live Birth. Muasher, Suheil J. // Fertility Weekly;6/16/2014, p7 

    The article presents a study which examines the correlation between oocyte number and rates of ovarian hyperstimulation syndrome (OHSS) and live birth in fresh autologous in vitro fertilization (IVF) cycles. The study suggests a significance increase in the risk of OHSS with no increase oocyte...

  • Serum anti-Müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients. Sahmay, Sezai; Cetin, Meral; Ocal, Pelin; Kaleli, Semih; Senol, Hulya; Birol, Fatih; Irez, Tulay // Reproductive Medicine & Biology;Mar2011, Vol. 10 Issue 1, p9 

    Purpose: To evaluate the clinical value of day 3 serum anti-Müllerian hormone (AMH) compared with day 3 serum follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG) day estradiol (E2) levels and antral follicle count (AFC) in the prediction of poor ovarian response in...

  • Higher rFSH Dose does not Improve Results.  // Fertility Weekly;9/6/2010, p3 

    The article discusses ovarian stimulation and recombinant follicle-stimulating hormone (rFSH). It states that FSH is the hormone required to stimulate multifollicular development during controlled ovarian hyperstimulation (COH). It notes that the participants of the study are predicted to have a...

  • Prediction of Outcome at Different AFC Thresholds in a Prospective Cohort. Jayaprakasan, Kannamannadiar // Fertility Weekly;10/22/2012, p5 

    The article reports on the study, conducted by researchers K. Jayaprakasan and colleagues in Great Britain, that estimates the probabilities of in vitro fertilization (IVF) outcomes at different antral follicle count (AFC) cutoff levels. The study reveals that AFC is a significant predictor of...

  • A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology. Bühler, Klaus; Naether, Olaf G. J.; Bilger, Wilma // Reproductive Biology & Endocrinology;2014, Vol. 12 Issue 1, p1 

    Background Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) both have a role to play in follicular development during the natural menstrual cycle. LH supplementation during controlled ovarian stimulation (COS) for assisted reproductive technology (ART) is used for patients with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics